HomeNews

News

Regulatory

WTO issues joint indicative list of critical inputs for COVID-19 vaccines

Pharma -
The WTO Secretariat has published an indicative list compiling information on the critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines.
Manufacturing

RDIF and Serum Institute of India to start production of Sputnik vaccine in September

Pharma -
The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year.
Manufacturing

R-Pharm and Frontier Biotech will provide Russia with a new drug for the treatment of HIV

Pharma -
Aikening™ is a new fusion inhibitor. It is the first and only long-acting injectable (as IV infusion QW) available as a dual therapy for treatment-experienced patients with HIV-1 replication.
Drug Development

Sputnik V vaccine effective against new variants of coronavirus

Pharma -
Sputnik V pioneered the vaccine cocktail approach with two shots. The tests conducted by the Gamaleya Center have demonstrated validity of this approach.
Global Markets

SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX

Pharma -
In total, up to 380 million doses of CoronaVac® will be available to both self-financing participants of the Facility as well as those supported by the Gavi COVAX AMC.
Regulatory

Media allegations on the rise in medicine prices are manipulative

Pharma -
To date, the FAS Russia has already set 61 new economically reasonable prices for 22 medicines, ensuring their presence in the market.
1...121122123...141Page 122 of 141
spot_img

Expert Articles

spot_img